MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%

IQV — IQVIA Holdings Inc.

NYSE

IQVIA Holdings Inc.

CompareBack to Screener
$266.09
+7.88(+3.05%)
O
258.51
H
266.91
L
258.51
V
1.63M
⏱️ End-of-day dataAs of Oct 5, 2026

Chart

About IQV

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
SectorNot available
IPO DateMay 9, 2013
Employees94,000
Stock ExchangeNYSE
Ticker SymbolIQV

Key Financial Statistics

Market Cap$42.50B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$154.50 - $277.40
52-Week Avg Volume1.67M
VWAP$264.20
Transactions32,393
Total Recorded Bars3,372 days